Stocks and Investing Stocks and Investing
Fri, October 30, 2020

David Lebovitz Downgraded (BPMC) to Hold on, Oct 30th, 2020


Published on 2024-10-27 14:34:13 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Downgraded "Blueprint Medicines Corporation" (BPMC) to Hold on, Oct 30th, 2020.

David has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $120 on, Thursday, October 29th, 2020
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $122 on, Friday, October 16th, 2020
  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Increased Target to $100 on, Tuesday, October 13th, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, July 15th, 2020
Contributing Sources